VSTM – verastem, inc. (US:NASDAQ)
Stock Stats
News
Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026 [Yahoo! Finance]
Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026
Verastem (VSTM) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Verastem (VSTM) had its "buy" rating reaffirmed by BTIG Research. They now have a $19.00 price target on the stock.
Vectoring In On Verastem [Seeking Alpha]
Form DEF 14A Verastem, Inc. For: May 21
Form SCHEDULE 13G/A Verastem, Inc. Filed by: VANGUARD GROUP INC
Form 4 Verastem, Inc. For: Mar 20 Filed by: Calkins Daniel
Form 8-K Verastem, Inc. For: Mar 04
Form 10-K Verastem, Inc. For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.